指南与共识乳腺CTMRUS乳腺X线

ACR适用性标准:基于乳腺密度的补充乳腺癌筛查

ACR Appropriateness Criteria® Supplemental Breast Cancer Screening Based on Breast Density.
指南 / 共识 · J Am Coll Radiol · 2021-01-01

基于乳腺密度的补充乳腺癌筛查指南:对于乳腺不致密的平均风险女性,数字乳腺断层合成筛查敏感度高,无需额外补充筛查;对于致密乳腺的平均风险女性,可考虑补充对比增强乳腺摄影、筛查超声、乳腺MRI或简化乳腺MRI;中风险女性可能受益于乳腺MRI或简化乳腺MRI;高风险女性无论乳腺密度如何,均有强证据支持乳腺MRI筛查,也可考虑对比增强乳腺摄影、全乳腺超声或简化乳腺MRI。

要点

  • 平均风险且乳腺不致密女性,数字乳腺断层合成筛查敏感度高,不推荐额外补充筛查。
  • 平均风险且致密乳腺女性,可考虑补充对比增强乳腺摄影、筛查超声、乳腺MRI或简化乳腺MRI。
  • 高风险女性无论乳腺密度如何,均有强证据支持乳腺MRI筛查,也可考虑对比增强乳腺摄影、全乳腺超声或简化乳腺MRI。

核心结论

  • 补充筛查应根据患者风险水平和乳腺密度个体化考虑;高风险女性有强证据支持乳腺MRI筛查,平均风险致密乳腺女性可考虑补充筛查,平均风险不致密乳腺女性无需补充筛查。

研究设计与样本

  • 美国放射学会(ACR)适用性标准,由多学科专家小组每年审查,基于同行评审期刊的广泛文献分析,采用RAND/UCLA适用性方法和GRADE分级对影像检查的适用性进行评级;证据不足或模棱两可时,专家意见可补充证据。

临床应用与阅片要点

  • 平均风险且乳腺不致密女性,数字乳腺断层合成筛查敏感度高,无需额外补充筛查;平均风险且致密乳腺女性,可考虑补充对比增强乳腺摄影、筛查超声、乳腺MRI或简化乳腺MRI;中风险女性,新兴证据提示可能受益于乳腺MRI或简化乳腺MRI;中风险且致密乳腺女性,可考虑补充对比增强乳腺摄影或筛查超声;高风险女性无论乳腺密度如何,均有强证据支持乳腺MRI筛查,也可考虑对比增强乳腺摄影、全乳腺超声或简化乳腺MRI。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Mammography remains the only validated screening tool for breast cancer, however, there are limitations to mammography. One of the limitations of mammography is the variable sensitivity based on breast density. Supplemental screening may be considered based on the patient's risk level and breast density. For average-risk women with nondense breasts, the sensitivity of digital breast tomosynthesis (DBT) screening is high; additional supplemental screening is not warranted in this population. For average-risk women with dense breasts, given the decreased sensitivity of mammography/DBT, this population may benefit from additional supplemental screening with contrast-enhanced mammography, screening ultrasound (US), breast MRI, or abbreviated breast MRI. In intermediate-risk women, there is emerging evidence suggesting that women in this population may benefit from breast MRI or abbreviated breast MRI. In intermediate-risk women with dense breasts, given the decreased sensitivity of mammography/DBT, this population may benefit from additional supplemental screening with contrast-enhancedmammography or screening US. There is strong evidence supporting screening high-risk women with breast MRI regardless of breast density. Contrast-enhanced mammography, whole breast screening US, or abbreviated breast MRI may be also considered. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.

来源:J Am Coll Radiol,查看原文。版权归原作者所有。

引用

  1. Weinstein SP, Slanetz PJ, Lewin AA, et al. ACR Appropriateness Criteria® Supplemental Breast Cancer Screening Based on Breast Density. J Am Coll Radiol. 2021. PMID: 34794600. doi:10.1016/j.jacr.2021.09.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。